hg_49862.1

Basic information about the TSS

---

TSS ID: hg_49862.1 Species: human Chr: chr4		Start: 143513661 End: 143513779 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000283131.4 BC023144 AB010882 AK308424 Distance: 0 GeneID: 8467 HGNC/MGI_ID: HGNC:11101 UniProt_ID: O60264

Gene_name: SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5 Gene_symbol: SMARCA5 Gene_synonyms: ISWI hISWI hSNF2H Gene_source: HGNC:11101

TATA-Box annotation

---

Distance to TSS:	18
Nearest PromoterID:	NM_003601
Entrez ID:	8467
Nearest Unigene:	Hs.558422
Nearest Refseq:	NM_003601
Nearest Ensembl:	ENSG00000153147
Gene Name:	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5
Gene Alias:	ISWI|SNF2H|WCRF135|hISWI|hSNF2H
Gene Description:	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5
Gene Type:	protein-coding
CpG%:	0.115
GC%:	0.696517
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@SMARCA5 p2@SMARCA5
Sample		p1@SMARCA5	p2@SMARCA5
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	32.14	37.01
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	33.38	41.88
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	33.95	43.98
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	29.94	34.31
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	35.54	31.50
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	37.41	37.02
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	78.44	36.39
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	62.49	34.15
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	77.58	32.70
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	91.00	23.76
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	99.44	20.62
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	123.59	25.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	29.82	19.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	27.66	17.14
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	26.13	15.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	22.89	16.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	24.90	11.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	21.09	19.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	19.19	15.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	22.87	17.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	25.39	16.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	21.92	17.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	23.14	17.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	20.38	15.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	19.87	18.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	19.31	9.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	20.33	16.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	30.18	18.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	20.68	15.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	25.88	19.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	25.12	14.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	20.71	18.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	21.74	17.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	22.76	20.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	18.32	19.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	25.87	18.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	21.26	18.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	23.57	17.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	27.82	21.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	27.61	12.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	19.29	17.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	23.13	22.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	26.36	17.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	27.10	19.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	30.92	18.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	32.11	18.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	27.35	14.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	30.10	16.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	31.12	16.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	26.49	17.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	25.21	18.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	38.03	16.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	97.95	27.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	39.03	13.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	30.16	10.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	32.72	36.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	24.80	22.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	35.00	16.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	26.98	10.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	25.78	22.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	33.14	7.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	31.40	11.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	22.29	22.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	22.08	9.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	40.29	12.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	33.01	7.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	96.98	32.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	102.67	71.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	30.23	5.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	27.77	9.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	27.68	10.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	33.45	6.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	37.12	5.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	43.42	5.20
Adipocyte - breast, donor1	11376-118A8	30.25	20.43
Adipocyte - breast, donor2	11327-117E4	27.27	18.61
Adipocyte - omental, donor1	11473-119C6	29.14	25.83
Adipocyte - omental, donor2	11474-119C7	13.45	11.96
Adipocyte - omental, donor3	11475-119C8	14.74	14.07
Adipocyte - perirenal, donor1	11476-119C9	12.12	6.38
Adipocyte - subcutaneous, donor1	11259-116F8	8.80	5.50
Adipocyte - subcutaneous, donor2	11336-117F4	23.48	8.58
Adipocyte - subcutaneous, donor3	11408-118E4	19.64	9.91
Adipocyte differentiation, day04, donor1	13019-139D4	58.67	24.06
Adipocyte differentiation, day04, donor2	13022-139D7	42.21	16.21
Adipocyte differentiation, day04, donor3	13025-139E1	49.06	18.12
Adipocyte differentiation, day04, donor4	13028-139E4	54.08	21.75
Adipocyte differentiation, day08, donor1	13020-139D5	43.27	25.50
Adipocyte differentiation, day08, donor2	13023-139D8	50.35	14.85
Adipocyte differentiation, day08, donor3	13026-139E2	29.33	12.26
Adipocyte differentiation, day08, donor4	13029-139E5	30.05	13.91
Adipocyte differentiation, day12, donor1	13021-139D6	24.95	9.15
Adipocyte differentiation, day12, donor2	13024-139D9	26.62	8.79
Adipocyte differentiation, day12, donor3	13027-139E3	29.45	10.47
Adipocyte differentiation, day12, donor4	13030-139E6	28.92	10.96
Alveolar Epithelial Cells, donor1	11510-119G7	13.92	9.06
Alveolar Epithelial Cells, donor2	11590-120G6	11.83	3.59
Alveolar Epithelial Cells, donor3	11671-122G6	2.40	2.40
Amniotic Epithelial Cells, donor1	11533-120A3	31.12	15.47
Amniotic Epithelial Cells, donor2	11613-122A2	5.02	3.35
Amniotic Epithelial Cells, donor3	11694-123A2	12.53	9.86
Anulus Pulposus Cell, donor1	11248-116E6	27.92	17.05
Anulus Pulposus Cell, donor2	11463-119B5	21.06	12.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	21.57	13.03
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	23.01	13.46
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	17.12	14.98
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	26.60	13.45
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	24.03	12.65
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	15.84	6.60
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	19.17	10.07
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	22.33	9.22
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	13.07	5.94
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	30.88	10.92
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	21.04	19.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	13.79	10.03
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	26.19	13.18
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	19.11	5.46
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	16.13	9.35
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	16.61	15.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	20.78	14.17
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	20.58	10.42
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	28.29	14.63
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	20.07	11.78
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	6.00	9.61
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	38.94	17.70
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	21.96	13.55
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	25.17	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	26.70	12.62
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	18.59	12.90
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	24.23	9.69
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	21.09	8.55
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	20.74	10.26
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	13.16	6.71
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	17.36	11.73
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	18.97	10.61
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	18.55	8.56
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	23.40	10.53
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	20.77	9.03
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	13.07	7.13
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	19.83	8.14
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	20.12	14.26
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	17.15	5.72
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	15.54	10.36
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	16.09	10.58
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	11.31	4.35
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	17.01	12.28
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	18.99	10.85
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	18.53	6.95
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	29.58	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	18.87	10.72
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	11.43	9.02
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	21.87	16.04
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	17.93	14.25
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	22.95	7.65
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	18.81	6.10
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	20.85	11.77
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	16.22	10.71
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	24.38	9.56
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	23.50	9.76
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	18.31	6.10
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	26.59	11.08
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	27.01	10.86
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	14.54	8.00
Astrocyte - cerebellum, donor1	11500-119F6	21.74	19.28
Astrocyte - cerebellum, donor2	11580-120F5	11.64	11.47
Astrocyte - cerebellum, donor3	11661-122F5	8.18	12.17
Astrocyte - cerebral cortex, donor1	11235-116D2	70.41	58.91
Astrocyte - cerebral cortex, donor2	11316-117D2	67.94	55.16
Astrocyte - cerebral cortex, donor3	11392-118C6	69.21	59.51
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	134.87	73.74
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	130.04	72.16
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	148.16	83.41
Basophils, donor1	12241-129G9	38.71	20.92
Basophils, donor2	12242-129H1	99.94	42.21
Basophils, donor3	12243-129H2	51.16	27.78
Bronchial Epithelial Cell, donor1	11511-119G8	7.55	6.25
Bronchial Epithelial Cell, donor2	11591-120G7	3.20	1.37
Bronchial Epithelial Cell, donor3	11672-122G7	35.87	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	25.73	8.16
Bronchial Epithelial Cell, donor5	11457-119A8	16.01	4.57
Bronchial Epithelial Cell, donor6	11461-119B3	9.21	2.99
Bronchial Epithelial Cell, donor7	11769-123I5	29.33	11.16
Burkitt's lymphoma cell line:DAUDI	10422-106C8	90.69	68.94
Burkitt's lymphoma cell line:RAJI	10476-106I8	133.22	64.28
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	76.75	29.42
CD133+ stem cells - cord blood derived, pool1	12223-129E9	144.79	41.37
CD14+ Monocytes, donor1	11224-116B9	68.75	33.81
CD14+ Monocytes, donor2	11305-117B9	58.09	38.42
CD14+ Monocytes, donor3	11381-118B4	65.42	32.71
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	93.12	17.27
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	93.25	15.16
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	101.25	15.45
CD14+ monocytes - mock treated, donor1	11863-125A9	47.85	21.68
CD14+ monocytes - mock treated, donor2	11873-125C1	49.49	22.03
CD14+ monocytes - mock treated, donor3	11883-125D2	67.51	31.98
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	42.18	26.45
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	43.89	37.54
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	48.10	25.04
CD14+ monocytes - treated with BCG, donor1	11860-125A6	35.44	26.04
CD14+ monocytes - treated with BCG, donor2	11870-125B7	45.05	29.38
CD14+ monocytes - treated with BCG, donor3	11880-125C8	55.93	31.56
CD14+ monocytes - treated with Candida, donor1	11868-125B5	48.23	38.40
CD14+ monocytes - treated with Candida, donor2	11878-125C6	61.25	44.88
CD14+ monocytes - treated with Candida, donor3	11888-125D7	52.14	28.84
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	42.84	22.91
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	49.09	24.15
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	53.92	21.03
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	57.42	32.72
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	64.24	42.07
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	55.87	40.15
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	57.83	23.13
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	52.16	25.12
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	63.96	28.19
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	79.91	37.29
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	99.34	51.78
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	111.87	57.03
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	40.11	31.39
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	42.74	34.94
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	57.55	34.92
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	92.95	27.44
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	112.65	44.74
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	105.79	40.83
CD14+CD16+ Monocytes, donor1	11789-124B7	64.95	11.55
CD14+CD16+ Monocytes, donor2	11801-124D1	62.60	9.70
CD14+CD16+ Monocytes, donor3	11912-125G4	51.34	7.36
CD14+CD16- Monocytes, donor1	11788-124B6	80.35	18.84
CD14+CD16- Monocytes, donor2	11799-124C8	54.14	9.43
CD14+CD16- Monocytes, donor3	11910-125G2	123.52	21.18
CD14-CD16+ Monocytes, donor1	11790-124B8	67.88	11.23
CD14-CD16+ Monocytes, donor2	11800-124C9	65.87	10.76
CD14-CD16+ Monocytes, donor3	11911-125G3	67.16	7.16
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	83.32	8.13
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	92.21	14.92
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	86.99	18.64
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	106.07	33.58
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	127.58	20.37
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	106.69	23.16
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	98.04	21.18
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	116.01	15.82
CD19+ B Cells, donor1	11544-120B5	131.50	102.74
CD19+ B Cells, donor2	11624-122B4	95.03	81.25
CD19+ B Cells, donor3	11705-123B4	101.47	95.41
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	175.36	29.09
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	129.44	17.58
CD34+ Progenitors, donor1	11545-120B6	60.24	30.12
CD34+ Progenitors, donor2	11625-122B5	60.68	28.09
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	87.18	29.68
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	81.62	27.28
CD4+ T Cells, donor1	11225-116C1	264.94	120.33
CD4+ T Cells, donor2	11306-117C1	162.89	72.87
CD4+ T Cells, donor3	11382-118B5	154.94	69.23
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	88.06	14.80
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	95.90	17.07
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	93.71	13.51
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	164.04	64.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	146.79	59.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	125.26	65.92
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	77.17	10.26
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	58.30	9.32
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	55.29	11.61
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	99.52	37.66
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	122.29	31.44
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	122.31	34.76
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	91.92	15.18
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	56.31	8.73
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	47.78	7.68
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	157.72	54.66
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	191.33	60.03
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	157.80	43.04
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	100.50	16.32
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	70.18	12.13
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	76.71	15.76
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	136.51	45.50
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	120.44	24.70
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	154.71	42.27
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	157.37	32.17
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	117.24	12.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	122.83	18.15
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	150.93	31.85
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	188.95	24.78
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	147.84	23.10
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	136.44	23.28
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	139.88	29.08
CD8+ T Cells, donor1	11226-116C2	181.05	101.49
CD8+ T Cells, donor2	11307-117C2	149.80	76.59
CD8+ T Cells, donor3	11383-118B6	178.51	112.11
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	38.54	4.36
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	38.58	4.07
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	40.49	3.56
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	41.13	6.90
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	39.12	3.84
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	38.66	5.68
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	45.63	2.39
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	42.11	3.16
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	48.78	3.28
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	55.55	1.81
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	44.45	3.78
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	47.96	4.26
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	93.68	3.50
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	110.67	4.10
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	114.86	3.73
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	39.98	3.96
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	38.27	4.89
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	36.06	4.48
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	53.24	4.75
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	47.67	3.08
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	44.56	2.56
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	52.02	3.82
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	55.17	2.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	46.14	3.03
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	236.87	4.01
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	242.00	6.29
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	243.43	7.01
Cardiac Myocyte, donor1	11525-119I4	31.07	20.11
Cardiac Myocyte, donor2	11605-120I3	33.60	14.82
Cardiac Myocyte, donor3	11686-122I3	33.67	24.73
Chondrocyte - de diff, donor1	11261-116G1	28.77	12.48
Chondrocyte - de diff, donor2	11338-117F6	18.48	11.73
Chondrocyte - de diff, donor3	11410-118E6	21.28	11.95
Chondrocyte - re diff, donor2	11339-117F7	25.96	19.70
Chondrocyte - re diff, donor3	11411-118E7	13.35	12.13
Ciliary Epithelial Cells, donor1	11242-116D9	57.03	63.69
Ciliary Epithelial Cells, donor2	11323-117D9	31.21	35.27
Ciliary Epithelial Cells, donor3	11399-118D4	36.37	42.74
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	65.75	40.62
Corneal Epithelial Cells, donor1	11526-119I5	7.90	2.42
Corneal Epithelial Cells, donor2	11606-120I4	10.24	9.10
Corneal Epithelial Cells, donor3	11687-122I4	8.95	5.37
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	68.02	11.06
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	75.70	13.25
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	55.21	10.35
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	42.33	9.94
Dendritic Cells - plasmacytoid, donor1	11228-116C4	87.80	34.85
Dendritic Cells - plasmacytoid, donor2	11309-117C4	85.53	23.50
Dendritic Cells - plasmacytoid, donor3	11385-118B8	107.92	24.20
Endothelial Cells - Aortic, donor0	11207-116A1	33.19	16.68
Endothelial Cells - Aortic, donor1	11263-116G3	11.74	7.04
Endothelial Cells - Aortic, donor2	11340-117F8	22.06	12.44
Endothelial Cells - Aortic, donor3	11412-118E8	18.87	8.65
Endothelial Cells - Artery, donor1	11264-116G4	12.80	8.44
Endothelial Cells - Artery, donor2	11341-117F9	36.47	17.18
Endothelial Cells - Artery, donor3	11413-118E9	28.40	16.30
Endothelial Cells - Lymphatic, donor1	11236-116D3	40.34	19.95
Endothelial Cells - Lymphatic, donor2	11317-117D3	47.47	18.86
Endothelial Cells - Lymphatic, donor3	11393-118C7	68.22	27.34
Endothelial Cells - Microvascular, donor1	11265-116G5	19.61	10.70
Endothelial Cells - Microvascular, donor2	11342-117G1	16.66	5.73
Endothelial Cells - Microvascular, donor3	11414-118F1	14.75	8.22
Endothelial Cells - Thoracic, donor1	11266-116G6	52.02	21.21
Endothelial Cells - Thoracic, donor2	11343-117G2	14.68	6.81
Endothelial Cells - Umbilical vein, donor1	11243-116E1	101.01	38.02
Endothelial Cells - Umbilical vein, donor2	11324-117E1	66.05	18.25
Endothelial Cells - Umbilical vein, donor3	11400-118D5	85.61	26.87
Endothelial Cells - Vein, donor1	11267-116G7	22.75	10.24
Endothelial Cells - Vein, donor2	11344-117G3	24.45	10.48
Endothelial Cells - Vein, donor3	11416-118F3	29.83	14.13
Eosinophils, donor1	12244-129H3	137.22	45.74
Eosinophils, donor2	12245-129H4	229.39	70.96
Eosinophils, donor3	12246-129H5	171.21	46.37
Esophageal Epithelial Cells, donor1	11507-119G4	9.28	3.91
Esophageal Epithelial Cells, donor2	11587-120G3	10.40	4.16
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	16.27
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	15.60	16.01
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	9.53	4.49
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	19.07	8.67
Fibroblast - Aortic Adventitial, donor1	11245-116E3	27.41	21.35
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	49.54	43.12
Fibroblast - Aortic Adventitial, donor2	11326-117E3	18.35	13.08
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	44.79	44.27
Fibroblast - Aortic Adventitial, donor3	11401-118D6	33.88	19.93
Fibroblast - Cardiac, donor1	11268-116G8	12.25	15.42
Fibroblast - Cardiac, donor2	11345-117G4	10.61	21.22
Fibroblast - Cardiac, donor3	11417-118F4	10.72	9.62
Fibroblast - Cardiac, donor4	11452-119A3	61.53	43.04
Fibroblast - Cardiac, donor5	11456-119A7	34.64	16.75
Fibroblast - Cardiac, donor6	11460-119B2	36.99	18.95
Fibroblast - Choroid Plexus, donor1	11492-119E7	24.12	21.97
Fibroblast - Choroid Plexus, donor2	11572-120E6	26.75	19.85
Fibroblast - Choroid Plexus, donor3	11653-122E6	20.51	27.83
Fibroblast - Conjunctival, donor1	11531-120A1	21.68	12.69
Fibroblast - Conjunctival, donor3	11692-122I9	46.13	29.00
Fibroblast - Dermal, donor1	11269-116G9	27.70	11.50
Fibroblast - Dermal, donor2	11346-117G5	17.45	15.09
Fibroblast - Dermal, donor3	11418-118F5	21.52	14.87
Fibroblast - Dermal, donor4	11450-119A1	47.48	25.89
Fibroblast - Dermal, donor5	11454-119A5	53.03	26.69
Fibroblast - Dermal, donor6	11458-119A9	59.61	24.04
Fibroblast - Gingival, donor1	11237-116D4	47.06	26.24
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	47.68	29.34
Fibroblast - Gingival, donor2	11318-117D4	31.76	18.98
Fibroblast - Gingival, donor3	11394-118C8	41.38	25.62
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	60.26	13.51
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	32.95	16.21
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	51.13	25.88
Fibroblast - Gingival, donor6 (control)	11922-125H5	35.16	15.01
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	46.23	27.88
Fibroblast - Gingival, donor7 (control)	11924-125H7	31.88	21.94
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	39.00	22.91
Fibroblast - Gingival, donor8 (control)	11926-125H9	49.80	24.79
Fibroblast - Gingival, donor9 (control)	11927-125I1	50.62	32.28
Fibroblast - Lung, donor1	11270-116H1	10.87	4.08
Fibroblast - Lung, donor2	11347-117G6	46.26	37.30
Fibroblast - Lung, donor3	11419-118F6	24.27	15.83
Fibroblast - Lymphatic, donor1	11506-119G3	17.49	13.33
Fibroblast - Lymphatic, donor2	11586-120G2	9.79	5.59
Fibroblast - Lymphatic, donor3	11667-122G2	1.96	1.96
Fibroblast - Mammary, donor1	11540-120B1	25.98	19.49
Fibroblast - Mammary, donor2	11620-122A9	7.99	7.99
Fibroblast - Mammary, donor3	11701-123A9	11.91	5.96
Fibroblast - Periodontal Ligament, donor1	11238-116D5	55.67	31.23
Fibroblast - Periodontal Ligament, donor2	11319-117D5	66.44	33.83
Fibroblast - Periodontal Ligament, donor3	11395-118C9	67.01	32.74
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	32.82	20.61
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	18.90	14.58
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	36.42	18.67
Fibroblast - Pulmonary Artery, donor1	11250-116E8	36.81	20.23
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	21.54	12.60
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	10.69	8.02
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	18.98	14.23
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	63.11	60.53
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	24.33	23.27
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	29.56	21.09
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	50.84	35.80
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	39.51	30.12
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	56.18	52.13
Fibroblast - skin normal, donor1	11553-120C5	28.06	19.03
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	84.61	54.14
Fibroblast - skin normal, donor2	11561-120D4	42.90	18.59
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	84.63	63.77
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	33.72	24.69
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	46.16	28.04
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	53.53	46.97
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	39.09	21.41
Fibroblast - skin walker warburg, donor1	11554-120C6	27.83	20.58
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	12.08	11.60
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	221.60	66.48
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	40.96	9.59
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	34.32	15.08
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	38.52	19.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	47.53	21.46
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	79.62	29.09
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	74.65	40.20
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	103.27	74.74
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	116.92	100.10
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	100.92	50.92
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	101.24	66.97
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	112.08	98.86
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	119.70	57.40
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	92.87	63.68
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	103.31	86.49
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	100.11	83.98
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	91.06	59.90
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	61.95	68.39
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	85.27	74.20
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	66.28	45.13
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	53.39	45.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	69.13	56.05
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	76.72	49.84
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	50.23	53.19
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	69.46	78.05
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	63.90	44.46
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	49.60	56.66
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	62.43	82.62
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	95.77	81.67
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	74.30	92.71
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	66.26	87.27
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	56.99	78.90
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	74.38	78.20
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	77.38	67.38
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	39.82	55.29
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	53.03	74.48
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	49.53	50.03
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	34.83	51.36
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	51.78	72.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	43.77	53.65
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	35.92	53.88
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	45.58	62.35
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	32.43	46.35
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	37.10	45.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	42.02	55.72
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	35.79	36.45
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	33.67	45.17
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	51.85	53.33
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	32.09	33.69
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	43.61	37.79
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	38.86	43.78
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	35.24	37.95
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	38.16	41.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	30.05	33.99
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	59.50	51.57
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	33.51	33.24
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	24.61	38.33
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	78.03	74.21
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	182.34	114.06
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	105.85	89.36
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	171.24	131.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	64.78	32.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	61.88	32.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	134.67	64.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	121.27	32.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	91.29	52.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	83.43	30.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	111.29	57.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	78.77	50.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	92.66	46.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	86.64	36.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	74.39	44.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	85.63	39.87
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	66.27	42.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	87.15	43.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	62.84	42.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	54.29	50.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	76.74	49.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	47.06	35.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	81.32	22.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	67.93	45.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	72.72	51.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	52.68	21.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	61.89	39.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	47.92	36.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	38.12	24.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	53.94	52.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	66.76	55.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	42.24	34.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	35.39	41.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	44.06	37.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	50.87	45.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	66.21	52.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	46.87	43.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	37.77	41.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	44.34	42.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	39.06	46.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	34.76	45.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	32.23	31.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	43.19	31.54
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	17.12	20.54
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	17.46	16.22
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	15.74	5.62
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	20.62	19.03
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	13.37	11.28
Hep-2 cells mock treated, biol_rep1	11898-125E8	37.95	14.39
Hep-2 cells mock treated, biol_rep2	11899-125E9	51.32	17.05
Hep-2 cells mock treated, biol_rep3	11900-125F1	40.50	18.88
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	36.51	17.60
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	40.40	15.90
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	40.69	17.01
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	35.49	15.57
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	38.43	12.18
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	37.80	11.53
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	15.11	8.39
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	8.66	7.36
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	42.30	5.29
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	14.46	9.88
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	11.62	13.08
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	30.77	15.56
Hepatocyte, donor1	11523-119I2	35.11	19.37
Hepatocyte, donor2	11603-120I1	54.94	38.78
Hepatocyte, donor3	11684-122I1	39.88	17.79
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	51.56	31.98
Intestinal epithelial cells (polarized), donor1	11246-116E4	48.76	32.16
Iris Pigment Epithelial Cells, donor1	11530-119I9	32.11	28.13
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	12.74	15.92
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	26.70	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	15.23	9.69
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	10.01	10.01
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	12.81	12.81
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	9.14
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	30.86	4.87
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	13.34	11.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	14.52	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	13.23	7.94
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	14.41	8.87
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	20.95	10.48
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	11.97	15.75
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	12.37	7.73
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	12.92	9.04
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	6.44	12.88
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	23.90
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	5.70	13.04
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	14.27	11.75
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	28.74
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	9.64	8.84
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	11.08	6.46
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	8.97	5.66
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	16.33	7.26
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	14.74
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	12.91	12.91
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	15.25	8.89
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	10.84	10.20
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	14.58	5.47
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	11.43	10.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	3.32	6.64
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	20.85
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	11.11	10.19
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	10.54	14.05
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	15.72	9.43
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	20.86	22.95
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	17.70	8.85
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	22.69	6.48
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	17.44	10.46
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	15.75	4.50
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	20.91	6.97
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	16.00	7.47
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	16.63	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	5.70	11.40
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	13.81	4.60
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	0.00	6.05
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	15.86	0.00
Keratinocyte - epidermal, donor1	11272-116H3	31.58	15.26
Keratinocyte - epidermal, donor2	11349-117G8	12.88	2.93
Keratinocyte - epidermal, donor3	11421-118F8	34.17	15.05
Keratinocyte - oral, donor1	11251-116E9	66.75	39.96
Keratocytes, donor1	11527-119I6	25.44	12.72
Keratocytes, donor2	11607-120I5	12.89	9.37
Keratocytes, donor3	11688-122I5	41.10	26.68
Krukenberg tumor cell line:HSKTC	10687-109F3	129.68	21.98
Lens Epithelial Cells, donor1	11529-119I8	30.20	16.18
Lens Epithelial Cells, donor2	11609-120I7	49.71	58.13
Lens Epithelial Cells, donor3	11690-122I7	46.82	41.47
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	19.21	10.67
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	15.07	3.63
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	37.94	16.21
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	19.90	5.91
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	11.66	4.10
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	9.92	3.99
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	26.27	9.44
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	7.84	0.76
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	11.82	5.07
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	15.82	9.49
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	19.19	4.65
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	9.26	2.78
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	23.00	6.62
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	11.69	6.20
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	11.40	4.81
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	22.79	10.47
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	6.86	2.49
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	9.52	5.49
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	30.28	6.25
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	7.61	1.76
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	8.71	3.49
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	31.52	9.70
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	17.50	5.66
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	13.62	5.45
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	16.07	7.78
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	26.38	8.17
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	10.38	3.01
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	13.07	6.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	19.38	3.39
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	7.95	3.82
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	26.17	7.27
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	15.88	3.31
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	9.04	5.20
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	29.99	14.81
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	18.28	3.46
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	9.07	2.75
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	28.95	8.04
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	31.35	3.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	21.55	9.38
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	17.07	7.47
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	6.79	0.97
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	7.47	2.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	16.47	5.01
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	13.07	3.92
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	5.65	2.59
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	22.03	9.41
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	10.76	3.33
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	9.25	3.28
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	13.60	13.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	13.04	13.81
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	11.13	11.88
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	11.85	8.46
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	14.77	14.07
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	12.14	6.54
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	13.91	3.09
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	8.33	3.57
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	15.15	9.95
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	16.29	10.47
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	18.91	19.36
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	12.19	13.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	10.78	7.19
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	15.17	13.76
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	17.99	13.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	12.73	10.19
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	18.14	15.74
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	16.63	16.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	16.57	10.43
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	21.20	14.68
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	19.57	17.70
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	20.18	12.89
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	17.52	13.39
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	20.90	18.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	16.74	14.05
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	23.24	21.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	16.26	13.08
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	11.06	7.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	12.66	6.91
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	12.66	10.36
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	11.89	10.19
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	18.05	9.03
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	14.01	9.04
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	19.39	7.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	13.44	11.20
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	13.75	9.66
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	15.51	10.34
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	9.42	10.28
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	13.99	9.66
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	10.26	7.84
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	7.82	9.24
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	14.78	9.62
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	10.20	12.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	10.10	11.45
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	16.67	11.48
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	15.12	5.81
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	16.92	9.52
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	15.61	10.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	12.36	8.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	13.03	5.37
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	13.81	6.91
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	15.05	8.47
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	15.59	9.55
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	18.93	8.56
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	8.61	5.16
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	15.59	10.69
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	16.81	8.99
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	14.51	5.94
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	16.61	9.86
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	16.63	14.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	12.86	15.65
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	16.34	9.27
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	16.20	18.90
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	11.65	9.11
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	18.26	13.94
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	17.89	15.90
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	16.41	11.54
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	13.14	4.84
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	10.26	14.06
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	14.46	6.71
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	10.28	6.05
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	14.89	11.73
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	18.13	7.46
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	10.34	6.90
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	18.51	7.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	16.98	10.61
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	21.00	7.38
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	16.64	13.31
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	5.48	9.40
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	16.28	9.60
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	15.33	6.04
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	15.39	5.35
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	12.83	9.09
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	11.72	8.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	4.59	4.59
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	14.23	7.11
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	10.83	7.41
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	10.74	6.90
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	19.70	11.49
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	13.36	8.46
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	14.30	11.44
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	14.59	9.28
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	27.02	12.47
Macrophage - monocyte derived, donor1	11232-116C8	64.50	9.12
Macrophage - monocyte derived, donor2	11313-117C8	40.00	8.26
Macrophage - monocyte derived, donor3	11389-118C3	45.22	11.54
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	26.02	8.50
Mallassez-derived cells, donor2	11929-125I3	41.67	16.00
Mallassez-derived cells, donor3	11930-125I4	43.09	15.71
Mammary Epithelial Cell, donor1	11273-116H4	50.92	14.65
Mammary Epithelial Cell, donor2	11350-117G9	47.49	14.19
Mammary Epithelial Cell, donor3	11422-118F9	18.71	9.23
Mast cell - stimulated, donor1	11487-119E2	498.96	27.80
Mast cell, donor1	11563-120D6	113.44	10.81
Mast cell, donor2	11565-120D8	94.20	30.31
Mast cell, donor3	11566-120D9	102.21	40.30
Mast cell, donor4	11567-120E1	84.57	26.95
Mast cell, expanded and stimulated, donor5	11940-126A5	91.38	10.53
Mast cell, expanded and stimulated, donor8	11942-126A7	67.71	7.00
Mast cell, expanded, donor5	11939-126A4	87.99	5.05
Mast cell, expanded, donor8	11941-126A6	86.86	8.03
Melanocyte - dark, donor1	11502-119F8	44.38	29.35
Melanocyte - dark, donor2	11582-120F7	28.72	14.19
Melanocyte - dark, donor3	11663-122F7	55.92	33.32
Melanocyte - light, donor1	11274-116H5	21.39	14.10
Melanocyte - light, donor2	11351-117H1	10.24	10.92
Melanocyte - light, donor3	11423-118G1	6.07	2.60
Melanocyte, donor1 (MC+1)	12641-134G4	35.61	29.47
Melanocyte, donor2 (MC+2)	12739-135I3	40.61	23.40
Melanocyte, donor3 (MC+3)	12837-137B2	42.05	29.46
Meningeal Cells, donor1	11493-119E8	21.34	18.98
Meningeal Cells, donor2	11573-120E7	23.77	22.45
Meningeal Cells, donor3	11654-122E7	42.87	38.39
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	42.20	23.67
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	31.20	19.93
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	14.46	7.88
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	6.54	5.23
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	22.25	19.38
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	26.68	23.51
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	21.61	19.10
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	14.72	13.62
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	13.88	8.77
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	10.23	10.43
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	30.89	20.22
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	8.55	7.43
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	38.95	30.66
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	9.79	9.50
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	7.01	4.67
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	14.73	8.33
Mesenchymal stem cells - adipose, donor0	11217-116B2	37.93	17.72
Mesenchymal stem cells - hepatic, donor0	11218-116B3	36.90	30.02
Mesenchymal stem cells - umbilical, donor0	11214-116A8	33.38	15.97
Mesothelial Cells, donor1	11247-116E5	23.87	16.97
Mesothelial Cells, donor2	12156-128G5	20.02	11.51
Mesothelial Cells, donor3	11402-118D7	21.61	14.53
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	68.87	5.40
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	49.50	11.57
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	37.99	9.42
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	55.31	3.46
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	34.40	10.54
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	26.34	8.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	32.42	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	47.80	6.51
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	44.69	11.64
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	34.95	10.36
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	38.01	7.92
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	34.21	17.10
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	24.78	9.73
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	26.22	5.70
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	34.21	2.63
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	35.02	10.19
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	27.62	2.76
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	45.30	8.05
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	26.83	3.35
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	48.93	13.80
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	42.78	9.27
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	48.65	3.87
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	67.00	9.21
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	45.01	9.89
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	63.39	14.06
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	54.92	8.15
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	56.24	7.56
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	51.59	10.32
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	71.40	9.20
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	59.31	6.59
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	89.48	4.97
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	94.04	10.60
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	70.58	6.76
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	89.41	4.36
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	49.50	6.73
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	78.85	4.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	71.30	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	78.59	4.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	81.54	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	93.72	4.38
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	77.26	2.21
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	101.18	3.20
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	99.17	4.71
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	116.21	2.09
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	110.49	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	73.16	2.39
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	98.03	1.31
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	98.72	2.13
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	75.19	2.24
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	94.76	0.83
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	89.74	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	91.71	4.52
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	89.74	1.67
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	36.09	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	102.51	5.54
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	102.44	4.55
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	101.70	4.15
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	72.56	3.89
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	100.81	3.86
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	73.05	3.81
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	98.48	4.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	77.23	7.48
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	71.76	5.79
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	60.84	1.27
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	100.39	3.54
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	68.64	3.03
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	79.27	6.82
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	68.82	3.20
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	47.57	6.52
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	72.33	8.23
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	72.66	4.61
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	63.47	9.89
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	65.21	6.55
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	11.30	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	23.17	3.56
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	36.80	8.87
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	28.40	4.21
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	34.40	5.73
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	49.36	9.31
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	32.67	12.02
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	23.97	6.39
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	34.72	8.60
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	16.21	4.42
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	29.68	9.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	38.89	10.89
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	23.52	5.34
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	19.32	7.73
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	29.29	5.05
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	21.08	4.22
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	64.01	8.17
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	20.98	3.18
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	61.55	1.62
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	27.19	6.04
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	137.04	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	81.56	19.57
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	104.55	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	138.04	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	21.76	22.41
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	16.72	27.70
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	24.03	21.36
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	25.46	13.77
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	27.00	31.56
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	60.64	23.94
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	19.04	8.84
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	44.10	20.21
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	26.37	14.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	23.94	13.02
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	29.45	22.97
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	34.48	31.33
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	55.67	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	25.81	17.87
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	15.97	15.70
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	23.12	14.28
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	26.13	18.45
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	30.25	21.32
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	28.11	20.16
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	27.61	12.01
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	20.68	43.65
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	27.16	14.96
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	40.04	26.63
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	23.91	14.06
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	31.26	16.09
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	28.92	17.67
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	22.76	40.35
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	60.68	45.51
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	40.32	22.50
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	22.02	13.97
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	26.58	19.23
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	29.19	20.17
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	81.25	54.17
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	27.99	18.66
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	29.31	18.94
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	23.01	13.49
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	21.36	17.64
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	25.35	21.57
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	37.48	16.62
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	26.58	12.20
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	38.90	17.64
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	25.58	14.11
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	35.24	14.63
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	30.75	17.36
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	29.48	16.84
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	28.73	27.52
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	25.86	20.56
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	20.33	14.23
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	51.10	20.44
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	29.26	17.07
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	25.18	15.42
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	30.87	19.37
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	18.20	14.24
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	22.67	36.28
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	70.81	25.29
Myoblast, donor1	11241-116D8	29.94	15.16
Myoblast, donor2	11322-117D8	29.54	17.26
Myoblast, donor3	11398-118D3	44.23	25.73
NK T cell leukemia cell line:KHYG-1	10777-110G3	46.70	18.24
Natural Killer Cells, donor1	11230-116C6	157.76	86.10
Natural Killer Cells, donor2	11311-117C6	121.83	71.17
Natural Killer Cells, donor3	11387-118C1	123.87	67.36
Neural stem cells, donor1	11275-116H6	97.99	135.38
Neural stem cells, donor2	11352-117H2	100.13	152.13
Neurons, donor1	11494-119E9	46.65	51.21
Neurons, donor2	11574-120E8	53.50	51.96
Neurons, donor3	11655-122E8	32.06	49.33
Neutrophils, donor1	11233-116C9	154.98	35.26
Neutrophils, donor2	11314-117C9	98.56	20.29
Neutrophils, donor3	11390-118C4	219.90	72.08
Nucleus Pulposus Cell, donor1	11252-116F1	44.41	32.41
Nucleus Pulposus Cell, donor2	11409-118E5	16.61	11.72
Nucleus Pulposus Cell, donor3	11462-119B4	20.66	14.84
Olfactory epithelial cells, donor1	11933-125I7	10.05	12.11
Olfactory epithelial cells, donor2	11934-125I8	15.92	12.74
Olfactory epithelial cells, donor3	11935-125I9	16.69	14.98
Olfactory epithelial cells, donor4	11936-126A1	25.62	19.48
Oligodendrocyte - precursors, donor1	11496-119F2	68.01	28.29
Osteoblast - differentiated, donor1	11276-116H7	19.99	16.80
Osteoblast - differentiated, donor2	11353-117H3	8.00	10.29
Osteoblast - differentiated, donor3	11425-118G3	17.38	6.21
Osteoblast, donor1	11277-116H8	7.82	7.82
Osteoblast, donor2	11354-117H4	35.82	34.41
Osteoblast, donor3	11426-118G4	24.53	22.39
Pancreatic stromal cells, donor1	11249-116E7	37.74	28.72
Pericytes, donor1	11491-119E6	7.12	6.45
Pericytes, donor2	11571-120E5	7.47	7.47
Pericytes, donor3	11652-122E5	10.99	6.71
Perineurial Cells, donor1	11499-119F5	27.80	28.48
Perineurial Cells, donor2	11579-120F4	53.55	24.01
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	147.90	35.70
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	84.23	32.32
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	96.41	45.30
Placental Epithelial Cells, donor1	11278-116H9	20.57	11.96
Placental Epithelial Cells, donor2	11355-117H5	15.52	3.33
Placental Epithelial Cells, donor3	11427-118G5	14.14	10.60
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	12.03	4.75
Preadipocyte - breast, donor1	11467-119B9	23.26	18.01
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	59.13	53.12
Preadipocyte - breast, donor2	11328-117E5	18.46	14.41
Preadipocyte - omental, donor1	11468-119C1	22.70	22.91
Preadipocyte - omental, donor2	11329-117E6	27.93	22.26
Preadipocyte - omental, donor3	11403-118D8	22.35	18.77
Preadipocyte - perirenal, donor1	11469-119C2	9.84	2.95
Preadipocyte - subcutaneous, donor1	11279-116I1	15.05	11.98
Preadipocyte - subcutaneous, donor2	11356-117H6	38.43	18.42
Preadipocyte - subcutaneous, donor3	11428-118G6	18.90	17.03
Preadipocyte - visceral, donor1	11280-116I2	44.06	28.69
Preadipocyte - visceral, donor2	11357-117H7	26.69	18.87
Preadipocyte - visceral, donor3	11429-118G7	24.03	15.57
Prostate Epithelial Cells (polarized), donor1	11253-116F2	47.82	42.69
Prostate Epithelial Cells, donor2	11331-117E8	25.73	10.43
Prostate Epithelial Cells, donor3	11404-118D9	15.98	5.21
Prostate Stromal Cells, donor1	11254-116F3	31.78	16.97
Prostate Stromal Cells, donor2	11332-117E9	23.85	19.01
Prostate Stromal Cells, donor3	11405-118E1	19.50	17.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	17.88	5.84
Renal Cortical Epithelial Cells, donor2	11596-120H3	46.23	25.23
Renal Epithelial Cells, donor1	11517-119H5	19.78	20.29
Renal Epithelial Cells, donor2	11597-120H4	14.23	9.96
Renal Epithelial Cells, donor3	11678-122H4	63.73	30.28
Renal Glomerular Endothelial Cells, donor1	11514-119H2	14.30	6.81
Renal Glomerular Endothelial Cells, donor2	11594-120H1	18.06	6.20
Renal Glomerular Endothelial Cells, donor3	11675-122H1	65.27	30.86
Renal Glomerular Endothelial Cells, donor4	11783-124B1	15.97	5.99
Renal Mesangial Cells, donor1	11518-119H6	15.63	10.34
Renal Mesangial Cells, donor2	11598-120H5	14.42	13.79
Renal Mesangial Cells, donor3	11679-122H5	8.32	5.55
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	27.11	15.30
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	11.39	4.22
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	17.55	9.84
Retinal Pigment Epithelial Cells, donor0	11215-116A9	40.71	38.37
Retinal Pigment Epithelial Cells, donor1	11528-119I7	14.78	15.92
Retinal Pigment Epithelial Cells, donor2	11608-120I6	9.26	8.23
Retinal Pigment Epithelial Cells, donor3	11689-122I6	29.61	37.89
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	77.64	25.66
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	66.11	22.34
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	68.25	90.81
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	116.59	85.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	100.64	65.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	65.34	59.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	74.29	61.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	83.61	63.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	63.52	54.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	67.72	67.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	72.42	59.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	63.53	61.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	77.59	62.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	61.69	54.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	57.63	49.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	56.65	57.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	69.97	67.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	80.40	58.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	93.01	76.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	88.91	70.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	69.60	62.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	68.55	57.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	77.21	61.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	74.28	51.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	69.38	55.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	78.95	66.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	56.66	53.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	64.47	52.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	71.23	52.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	58.14	55.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	70.86	63.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	71.33	59.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	64.15	56.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	77.50	59.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	80.48	64.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	79.70	71.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	86.95	69.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	76.17	61.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	81.89	70.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	79.13	57.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	83.00	62.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	67.76	55.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	76.77	66.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	64.85	65.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	52.62	51.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	93.11	86.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	56.79	44.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	55.90	57.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	65.58	45.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	58.75	44.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	121.68	94.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	62.67	43.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	57.87	43.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	61.98	45.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	68.89	54.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	53.37	31.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	82.39	46.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	96.76	64.30
Schwann Cells, donor1	11498-119F4	11.47	9.78
Schwann Cells, donor2	11578-120F3	23.82	10.21
Schwann Cells, donor3	11659-122F3	26.07	27.17
Sebocyte, donor1	11220-116B5	33.96	7.67
Sebocyte, donor2	11301-117B5	14.71	9.19
Sebocyte, donor3	11378-118B1	7.42	5.77
Sertoli Cells, donor1	11255-116F4	49.70	24.85
Sertoli Cells, donor2	11333-117F1	33.89	11.30
Skeletal Muscle Cells, donor1	11281-116I3	31.67	22.08
Skeletal Muscle Cells, donor2	11358-117H8	6.51	3.61
Skeletal Muscle Cells, donor3	11430-118G8	21.74	11.70
Skeletal Muscle Cells, donor4	11451-119A2	36.92	25.14
Skeletal Muscle Cells, donor5	11455-119A6	42.36	23.19
Skeletal Muscle Cells, donor6	11459-119B1	54.48	22.01
Skeletal Muscle Satellite Cells, donor1	11240-116D7	53.05	32.01
Skeletal Muscle Satellite Cells, donor2	11321-117D7	40.95	28.82
Skeletal Muscle Satellite Cells, donor3	11397-118D2	50.70	40.97
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	34.71	31.34
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	13.03	7.96
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	10.18	9.08
Skin - palm, donor1	10286-104F7	51.04	8.06
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	27.68	8.94
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	67.07	37.62
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	35.83	10.78
Small Airway Epithelial Cells, donor1	11256-116F5	27.25	10.70
Small Airway Epithelial Cells, donor2	11334-117F2	27.99	12.10
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	86.90	47.15
Small Airway Epithelial Cells, donor3	11406-118E2	31.63	10.27
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	11.11	6.48
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	31.13	29.79
Smooth Muscle Cells - Aortic, donor0	11210-116A4	25.86	11.76
Smooth Muscle Cells - Aortic, donor1	11283-116I5	35.80	4.86
Smooth Muscle Cells - Aortic, donor2	11360-117I1	13.39	7.48
Smooth Muscle Cells - Aortic, donor3	11432-118H1	27.04	13.91
Smooth Muscle Cells - Bladder, donor1	11519-119H7	19.01	23.02
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	17.43	13.71
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	18.18	15.07
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	34.18	14.85
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	34.19	27.35
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	38.10	27.76
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	28.62	19.79
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	5.21	7.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	28.62	25.88
Smooth Muscle Cells - Carotid, donor1	11285-116I7	19.70	11.62
Smooth Muscle Cells - Carotid, donor2	11362-117I3	48.97	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	9.54	7.15
Smooth Muscle Cells - Colonic, donor1	11239-116D6	35.25	24.48
Smooth Muscle Cells - Colonic, donor2	11320-117D6	27.98	28.84
Smooth Muscle Cells - Colonic, donor3	11396-118D1	35.16	28.13
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	10.83	7.73
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	6.47	8.62
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	20.32	5.68
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	15.36	8.19
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	47.27	31.73
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	24.05	20.83
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	55.30	5.69
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	11.47	1.21
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	74.71	59.87
Smooth Muscle Cells - Prostate, donor1	11257-116F6	50.33	21.70
Smooth Muscle Cells - Prostate, donor2	11335-117F3	25.54	18.41
Smooth Muscle Cells - Prostate, donor3	11465-119B7	14.97	11.41
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	37.24	17.94
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	12.75	8.25
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	55.57	6.46
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	20.46	16.28
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	12.62	12.62
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	21.31	6.58
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	3.24	1.77
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	67.48	40.90
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	22.89	24.29
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	11.66	9.93
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	19.38	10.45
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	9.78	4.32
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	48.49	33.68
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	31.17	25.89
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	4.76	4.29
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	9.05	12.48
Smooth Muscle Cells - Uterine, donor1	11258-116F7	19.22	16.13
Smooth Muscle Cells - Uterine, donor3	11466-119B8	16.68	14.04
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	28.18	22.16
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	22.74	16.40
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	21.20	30.50
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	31.26	18.69
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	23.00	12.21
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	18.91	18.51
Smooth muscle cells - airway, control, donor1	11966-126D4	19.81	18.03
Smooth muscle cells - airway, control, donor2	11967-126D5	29.55	19.17
Smooth muscle cells - airway, control, donor3	11968-126D6	15.47	9.20
Smooth muscle cells - airway, control, donor4	11969-126D7	16.50	10.08
Synoviocyte, donor1	11291-117A4	18.01	26.76
Synoviocyte, donor2	11368-117I9	23.97	9.39
Synoviocyte, donor3	11440-118H9	20.33	8.71
Trabecular Meshwork Cells, donor1	11532-120A2	25.01	14.29
Trabecular Meshwork Cells, donor2	11612-122A1	9.91	11.89
Trabecular Meshwork Cells, donor3	11693-123A1	19.68	11.11
Tracheal Epithelial Cells, donor1	11292-117A5	25.66	9.46
Tracheal Epithelial Cells, donor2	11369-118A1	11.21	7.73
Tracheal Epithelial Cells, donor3	11441-118I1	9.74	4.01
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	81.81	28.79
Urethra, donor2	10319-105A4	68.34	39.57
Urothelial Cells, donor1	11520-119H8	7.97	1.33
Urothelial Cells, donor2	11600-120H7	5.61	3.20
Urothelial Cells, donor3	11681-122H7	6.19	2.75
Urothelial cells, donor0	11216-116B1	50.37	19.61
Whole blood (ribopure), donor090309, donation1	12179-129A1	95.21	18.69
Whole blood (ribopure), donor090309, donation2	12180-129A2	101.50	21.44
Whole blood (ribopure), donor090309, donation3	12181-129A3	54.76	12.32
Whole blood (ribopure), donor090325, donation1	12176-128I7	77.48	20.66
Whole blood (ribopure), donor090325, donation2	12177-128I8	79.02	17.43
Whole blood (ribopure), donor090612, donation1	12182-129A4	109.33	23.95
Whole blood (ribopure), donor090612, donation2	12183-129A5	94.53	18.36
Whole blood (ribopure), donor090612, donation3	12184-129A6	54.77	5.48
Wilms' tumor cell line:G-401	10809-111A8	59.46	44.90
Wilms' tumor cell line:HFWT	10597-108E3	44.88	15.84
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	37.43	29.61
achilles tendon, donor2	10292-104G4	45.46	10.33
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	93.06	72.92
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	154.16	61.53
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	128.92	73.01
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	157.28	38.64
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	50.60	8.71
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	86.50	14.38
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	80.03	31.03
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	80.64	21.59
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	72.28	21.64
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	64.07	19.03
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	59.25	27.42
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	85.81	35.10
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	113.40	41.83
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	110.29	41.42
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	124.79	40.33
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	75.29	21.84
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	27.14	11.52
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	81.34	15.35
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	88.33	17.92
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	87.65	20.62
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	98.93	23.59
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	53.90	27.62
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	83.05	36.69
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	213.69	11.15
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	67.80	29.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	133.89	30.97
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	110.59	11.25
adenocarcinoma cell line:IM95m	10796-110I4	61.70	16.96
adipose tissue, adult, pool1	10010-101C1	59.88	19.55
adipose, donor1	10184-103D4	100.86	99.10
adipose, donor2	10185-103D5	72.99	40.96
adipose, donor3	10186-103D6	87.13	43.84
adipose, donor4	10187-103D7	118.75	33.80
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	43.24	28.57
adrenal gland, adult, pool1	10081-102A9	21.83	18.19
adult T-cell leukemia cell line:ATN-1	10421-106C7	53.50	1.47
alveolar cell carcinoma cell line:SW 1573	10708-109H6	36.44	15.01
amniotic membrane cells, donor1	12235-129G3	42.20	17.39
amniotic membrane cells, donor2	12236-129G4	35.84	20.96
amniotic membrane cells, donor3	12237-129G5	33.29	16.50
amygdala - adult, donor10196	10167-103B5	56.92	43.87
amygdala, adult, donor10252	10151-102I7	73.00	63.67
amygdala, newborn, donor10223	10360-105E9	26.79	34.54
anaplastic carcinoma cell line:8305C	10428-106D5	51.82	24.96
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	75.23	15.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	101.55	56.79
aorta, adult, pool1	10052-101G7	34.72	20.40
appendix, adult	10189-103D9	107.90	39.98
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	73.26	61.22
artery, adult	10190-103E1	62.50	10.87
astrocytoma cell line:TM-31	10425-106D2	87.07	41.43
b cell line:RPMI1788	10427-106D4	101.27	38.22
basal cell carcinoma cell line:TE 354.T	10702-109G9	18.03	17.20
bile duct carcinoma cell line:HuCCT1	10432-106D9	51.70	19.35
bile duct carcinoma cell line:TFK-1	10496-107C1	61.43	13.73
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	43.06	10.07
bladder, adult, pool1	10011-101C2	74.31	26.94
blood, adult, pool1	10053-101G8	28.79	8.86
bone marrow stromal cell line:StromaNKtert	10686-109F2	57.38	29.97
bone marrow, adult	10192-103E3	65.46	24.97
brain, adult, donor1	10084-102B3	45.10	23.58
brain, adult, pool1	10012-101C3	71.83	46.99
brain, fetal, pool1	10085-102B4	32.06	34.73
breast carcinoma cell line:MCF7	10482-107A5	55.83	31.71
breast carcinoma cell line:MDA-MB-453	10419-106C5	80.64	35.45
breast, adult, donor1	10080-102A8	34.09	15.78
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	44.21	20.96
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	79.78	60.61
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	51.80	20.95
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	59.31	34.62
carcinoid cell line:NCI-H1770	10703-109H1	50.31	28.21
carcinoid cell line:NCI-H727	10735-110B6	47.47	40.47
carcinoid cell line:SK-PN-DW	10719-109I8	50.07	38.66
carcinosarcoma cell line:JHUCS-1	10642-109A3	101.95	53.50
caudate nucleus - adult, donor10196	10177-103C6	88.65	61.02
caudate nucleus, adult, donor10252	10164-103B2	75.46	57.39
caudate nucleus, adult, donor10258	10379-105H1	52.73	23.69
caudate nucleus, newborn, donor10223	10354-105E3	36.99	48.34
cerebellum - adult, donor10196	10173-103C2	122.36	75.75
cerebellum, adult, donor10252	10166-103B4	120.63	97.79
cerebellum, adult, pool1	10083-102B2	37.25	24.15
cerebellum, newborn, donor10223	10357-105E6	97.14	58.95
cerebral meninges, adult	10188-103D8	75.39	40.34
cerebrospinal fluid, donor2	10294-104G6	44.58	10.96
cervical cancer cell line:D98-AH2	10552-107I3	56.08	15.53
cervical cancer cell line:ME-180	10553-107I4	56.34	20.38
cervix, adult, pool1	10013-101C4	77.27	41.05
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	23.27	14.91
chondrosarcoma cell line:SW 1353	10700-109G7	23.51	3.92
choriocarcinoma cell line:BeWo	10423-106C9	96.81	14.66
choriocarcinoma cell line:SCH	10785-110H2	62.35	14.79
choriocarcinoma cell line:T3M-3	10618-108G6	77.08	22.77
chorionic membrane cells, donor1	12238-129G6	43.31	17.95
chorionic membrane cells, donor2	12239-129G7	52.90	26.85
chorionic membrane cells, donor3	12240-129G8	50.55	19.23
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	46.45	19.19
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	56.28	22.09
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	95.88	24.92
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	78.07	36.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	86.35	39.91
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	77.37	46.42
chronic myelogenous leukemia cell line:K562	10454-106G4	98.05	26.50
chronic myelogenous leukemia cell line:KU812	10409-106B4	174.88	64.90
clear cell carcinoma cell line:JHOC-5	10638-108I8	48.00	18.74
clear cell carcinoma cell line:TEN	10636-108I6	37.65	36.61
colon carcinoma cell line:CACO-2	10513-107D9	70.47	42.10
colon carcinoma cell line:COLO-320	10420-106C6	96.54	109.84
colon, adult, donor1	10082-102B1	47.60	15.47
colon, adult, pool1	10014-101C5	84.95	28.55
colon, fetal, donor1	10070-101I7	44.50	34.61
common myeloid progenitor CMP, donor1	12130-128D6	220.01	114.59
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	213.74	11.47
cord blood derived cell line:COBL-a 24h infection	10453-106G3	100.97	7.24
cord blood derived cell line:COBL-a untreated	10449-106F8	113.66	5.64
corpus callosum, adult, pool1	10042-101F6	101.61	75.40
cruciate ligament, donor2	10295-104G7	55.92	19.45
diaphragm, fetal, donor1	10069-101I6	34.51	22.47
diencephalon, adult	10193-103E4	69.84	51.12
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	58.09	49.14
ductal cell carcinoma cell line:KLM-1	10438-106E6	96.16	31.54
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	41.64	19.02
ductus deferens, adult	10196-103E7	91.69	28.41
duodenum, fetal, donor1, tech_rep1	10071-101I8	46.09	17.28
duodenum, fetal, donor1, tech_rep2	10071-101I8	62.53	38.25
dura mater, adult, donor1	10041-101F5	38.16	17.59
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	157.89	19.10
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	37.83	35.39
embryonic pancreas cell line:1B2C6	10604-108F1	53.65	12.95
embryonic pancreas cell line:1C3D3	10605-108F2	29.97	10.29
embryonic pancreas cell line:1C3IKEI	10606-108F3	50.94	12.35
embryonic pancreas cell line:2C6	10603-108E9	57.79	6.57
endometrial carcinoma cell line:OMC-2	10497-107C2	71.73	30.84
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	31.90	14.68
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	35.70	25.41
epidermoid carcinoma cell line:A431	10426-106D3	63.92	25.12
epidermoid carcinoma cell line:Ca Ski	10431-106D8	66.43	31.46
epididymis, adult	10197-103E8	72.84	36.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	49.32	22.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	45.22	6.29
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	58.84	22.80
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	74.21	20.67
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	58.48	23.75
esophagus, adult, pool1	10015-101C6	59.78	24.10
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	172.83	60.61
eye - muscle inferior rectus, donor1	10272-104E2	48.29	16.90
eye - muscle lateral, donor2	10298-104H1	39.98	21.04
eye - muscle medial, donor2	10299-104H2	32.74	17.86
eye - muscle superior, donor2	10297-104G9	59.62	19.49
eye - vitreous humor, donor1	10268-104D7	68.50	17.49
eye, fetal, donor1	10054-101G9	43.98	32.80
fibrosarcoma cell line:HT-1080	10758-110E2	30.77	20.64
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	37.99	13.06
frontal lobe, adult, pool1	10040-101F4	80.31	64.36
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	86.77	33.03
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	70.77	28.25
gall bladder, adult	10198-103E9	56.01	32.83
gamma delta positive T cells, donor1	11937-126A2	103.61	26.31
gamma delta positive T cells, donor2	11938-126A3	69.10	25.02
gastric adenocarcinoma cell line:MKN1	10614-108G2	50.90	18.80
gastric adenocarcinoma cell line:MKN45	10612-108F9	109.47	29.40
gastric cancer cell line:AZ521	10549-107H9	71.81	56.24
gastric cancer cell line:GSS	10560-108A2	40.27	16.47
gastrointestinal carcinoma cell line:ECC12	10615-108G3	42.95	56.66
giant cell carcinoma cell line:LU65	10487-107B1	54.62	9.06
giant cell carcinoma cell line:Lu99B	10433-106E1	54.58	32.33
glassy cell carcinoma cell line:HOKUG	10688-109F4	67.84	13.72
glioblastoma cell line:A172, tech_rep1	10444-106F3	49.19	27.76
glioblastoma cell line:A172, tech_rep2	10444-106F3	55.05	25.98
glioblastoma cell line:T98G	10485-107A8	40.62	21.74
glioma cell line:GI-1	10413-106B8	33.10	27.53
globus pallidus - adult, donor10196	10175-103C4	75.81	33.53
globus pallidus, adult, donor10252	10161-103A8	156.46	89.58
globus pallidus, adult, donor10258	10367-105F7	110.91	58.88
globus pallidus, newborn, donor10223	10364-105F4	40.50	34.11
granulocyte macrophage progenitor, donor1	12131-128D7	271.63	85.65
granulocyte macrophage progenitor, donor2	12135-128E2	54.64	32.79
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	5.23
granulosa cell tumor cell line:KGN	10624-108H3	32.64	18.56
hIPS +CCl2, biol_rep1	14383-156B9	95.50	64.74
hIPS +CCl2, biol_rep2	14384-156C1	106.08	64.93
hIPS +CCl2, biol_rep3	14385-156C2	103.70	47.66
hIPS, biol_rep1	14380-156B6	53.18	38.81
hIPS, biol_rep2	14381-156B7	100.82	60.36
hIPS, biol_rep3	14382-156B8	70.62	50.76
hairy cell leukemia cell line:Mo	10712-109I1	51.43	13.51
heart - mitral valve, adult	10205-103F7	68.16	28.70
heart - pulmonic valve, adult	10206-103F8	67.46	27.19
heart - tricuspid valve, adult	10207-103F9	90.76	22.48
heart, adult, diseased post-infarction, donor1	10050-101G5	44.69	26.94
heart, adult, diseased, donor1	10051-101G6	30.23	16.61
heart, adult, pool1	10016-101C7	97.51	33.58
heart, fetal, pool1	10046-101G1	85.53	56.68
hepatic mesenchymal tumor cell line:LI90	10778-110G4	28.08	20.05
hepatoblastoma cell line:HuH-6	10633-108I3	64.22	26.16
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	65.75	64.31
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	66.88	64.09
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	69.12	61.04
hepatoma cell line:Li-7	10484-107A7	49.16	20.91
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	83.82	33.67
hippocampus - adult, donor10196	10169-103B7	76.65	37.85
hippocampus, adult, donor10252	10153-102I9	88.38	66.94
hippocampus, adult, donor10258	10374-105G5	62.74	36.85
hippocampus, newborn, donor10223	10363-105F3	35.25	28.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	111.08	91.55
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	82.67	58.12
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	88.86	61.70
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	99.24	83.45
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	92.18	116.71
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	99.46	80.86
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	83.79	73.28
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	96.73	71.52
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	102.60	60.48
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	104.66	70.33
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	90.48	70.88
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	91.57	65.98
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	97.18	61.34
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	89.91	61.41
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	91.64	77.68
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	123.33	113.97
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	124.72	111.63
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	85.96	93.96
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	70.27	53.31
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	71.85	61.84
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	64.84	66.09
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	57.97	58.79
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	69.67	46.74
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	75.63	55.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	90.52	53.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	86.44	50.78
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	108.20	70.23
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	97.17	68.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	93.76	52.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	94.42	54.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	87.91	42.92
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	85.01	44.50
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	72.09	38.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	62.63	46.53
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	77.99	47.71
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	52.42	37.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	102.16	59.65
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	101.61	52.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	109.76	54.63
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	113.69	75.18
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	367.62	230.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	100.94	92.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	102.34	62.94
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	92.28	52.84
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	82.21	54.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	63.25	52.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	107.80	86.94
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	47.14	45.26
immature langerhans cells, donor1	11904-125F5	72.89	39.47
immature langerhans cells, donor2	11905-125F6	32.48	17.43
insula, adult, pool1	10039-101F3	64.63	51.58
keratoacanthoma cell line:HKA-1	10791-110H8	29.91	11.71
kidney, adult, pool1	10017-101C8	58.98	31.44
kidney, fetal, pool1	10045-101F9	60.34	54.89
large cell lung carcinoma cell line:IA-LM	10509-107D5	79.53	37.49
large cell lung carcinoma cell line:NCI-H460	10839-111E2	20.05	9.68
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	31.93	10.09
left atrium, adult, donor1	10079-102A7	28.88	13.08
left ventricle, adult, donor1	10078-102A6	32.36	15.68
leiomyoblastoma cell line:G-402	10721-110A1	45.42	29.82
leiomyoma cell line:10964C	10569-108B2	9.70	7.90
leiomyoma cell line:15242A	10570-108B3	13.59	4.89
leiomyoma cell line:15425	10571-108B4	13.35	8.01
leiomyosarcoma cell line:Hs 5.T	10722-110A2	38.10	31.75
lens epithelial cell line:SRA 01/04	10647-109A8	49.14	15.68
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	55.61	29.16
liposarcoma cell line:KMLS-1	10782-110G8	33.12	14.53
liposarcoma cell line:SW 872	10726-110A6	31.07	23.51
liver, adult, pool1	10018-101C9	56.07	19.29
liver, fetal, pool1	10086-102B5	31.04	11.29
locus coeruleus - adult, donor10196	10182-103D2	91.14	58.62
locus coeruleus, adult, donor10252	10165-103B3	86.92	67.36
locus coeruleus, adult, donor10258	10375-105G6	56.99	41.47
locus coeruleus, newborn, donor10223	10362-105F2	47.95	79.08
lung adenocarcinoma cell line:A549	10499-107C4	28.51	15.64
lung adenocarcinoma cell line:PC-14	10408-106B3	59.29	19.99
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	53.52	23.46
lung, adult, pool1	10019-101D1	96.98	25.16
lung, fetal, donor1	10068-101I5	232.32	129.86
lung, right lower lobe, adult, donor1	10075-102A3	78.35	30.24
lymph node, adult, donor1	10077-102A5	46.39	18.93
lymphangiectasia cell line:DS-1	10727-110A7	67.51	17.75
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	202.69	81.05
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	111.28	23.79
mature adipocyte, donor1	12231-129F8	37.74	16.43
mature adipocyte, donor2	12232-129F9	44.83	14.94
mature adipocyte, donor3	12233-129G1	39.12	15.41
mature adipocyte, donor4	12234-129G2	50.54	12.11
maxillary sinus tumor cell line:HSQ-89	10414-106B9	92.68	55.51
medial frontal gyrus - adult, donor10196	10170-103B8	69.94	39.48
medial frontal gyrus, adult, donor10252	10150-102I6	88.64	75.59
medial frontal gyrus, adult, donor10258	10368-105F8	39.39	32.09
medial frontal gyrus, newborn, donor10223	10352-105E1	34.55	36.68
medial temporal gyrus - adult, donor10196	10183-103D3	57.21	46.24
medial temporal gyrus, adult, donor10252	10156-103A3	97.62	79.58
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	13.48	26.97
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	57.41	143.54
medial temporal gyrus, newborn, donor10223	10353-105E2	25.48	26.56
medulla oblongata - adult, donor10196	10174-103C3	56.46	40.24
medulla oblongata, adult, donor10252	10155-103A2	94.59	65.02
medulla oblongata, adult, pool1	10038-101F2	73.30	50.20
medulla oblongata, newborn, donor10223	10361-105F1	50.34	43.05
medulloblastoma cell line:D283 Med	10838-111E1	75.06	63.10
medulloblastoma cell line:ONS-76	10759-110E3	33.63	16.38
melanoma cell line:COLO 679	10514-107E1	50.31	46.14
melanoma cell line:G-361	10465-106H6	36.92	18.46
meningioma cell line:HKBMM	10691-109F7	28.22	3.44
merkel cell carcinoma cell line:MKL-1	10843-111E6	156.85	93.40
merkel cell carcinoma cell line:MS-1	10844-111E7	102.65	80.62
mesenchymal precursor cell - adipose, donor1	11747-123G1	29.92	13.04
mesenchymal precursor cell - adipose, donor2	11748-123G2	21.27	13.27
mesenchymal precursor cell - adipose, donor3	11749-123G3	20.71	14.49
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	14.89	10.11
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	13.67	12.71
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	25.68	15.27
mesenchymal precursor cell - cardiac, donor1	11752-123G6	14.76	9.10
mesenchymal precursor cell - cardiac, donor2	11753-123G7	18.98	16.10
mesenchymal precursor cell - cardiac, donor3	11754-123G8	20.16	16.31
mesenchymal precursor cell - cardiac, donor4	11755-123G9	36.60	14.72
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	40.12	19.06
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	23.05	11.53
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	33.07	18.96
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	31.07	12.57
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	16.74	9.60
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	20.49	16.18
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	19.14	10.76
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	16.19	11.40
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	49.93	20.56
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	21.37	19.88
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	26.52	14.79
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	26.14	17.67
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	23.46	14.02
mesenchymal stem cell line:Hu5/E18	10568-108B1	43.36	21.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	14.61	13.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	20.46	13.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	26.18	15.97
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	19.72	13.56
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	21.65	12.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	15.91	15.23
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	18.86	16.11
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	18.54	20.85
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	21.34	21.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	21.19	17.40
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	18.99	23.07
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	36.67	25.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	19.47	14.10
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	15.15	13.51
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	22.34	13.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	13.67	19.14
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	30.99	15.49
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	18.51	14.94
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	29.10	11.64
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	18.12	14.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	21.26	9.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	26.82	13.22
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	20.99	8.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	11.92	15.90
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	4.77	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	21.35	10.08
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	19.50	9.75
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	19.00	12.03
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	26.56	12.07
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	25.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	15.97	11.98
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	13.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	19.97	8.15
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	16.68	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	12.38	7.07
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	25.56	12.47
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	9.36	10.69
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	35.48	9.46
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	30.82	15.41
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	21.34	17.90
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	20.78	6.93
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	16.82	8.97
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	16.54	10.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	12.90	6.85
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	13.08	13.08
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	7.60	5.07
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	21.24	8.50
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	13.56	9.04
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	17.30	5.77
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	17.66	10.91
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	13.30	11.03
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	22.41	9.17
mesodermal tumor cell line:HIRS-BM	10696-109G3	54.16	22.44
mesothelioma cell line:ACC-MESO-1	10493-107B7	98.99	5.43
mesothelioma cell line:ACC-MESO-4	10494-107B8	76.22	28.26
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	29.92	12.82
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	26.30	12.43
mesothelioma cell line:Mero-25	10850-111F4	31.09	11.35
mesothelioma cell line:Mero-41	10851-111F5	35.94	13.45
mesothelioma cell line:Mero-48a	10852-111F6	24.14	11.51
mesothelioma cell line:Mero-82	10853-111F7	57.82	15.51
mesothelioma cell line:Mero-83	10854-111F8	27.75	17.19
mesothelioma cell line:Mero-84	10855-111F9	14.66	5.06
mesothelioma cell line:Mero-95	10856-111G1	32.92	13.25
mesothelioma cell line:NCI-H2052	10847-111F1	20.04	11.43
mesothelioma cell line:NCI-H226	10846-111E9	30.41	5.61
mesothelioma cell line:NCI-H2452	10848-111F2	32.29	9.05
mesothelioma cell line:NCI-H28	10845-111E8	32.83	19.34
mesothelioma cell line:No36	10857-111G2	21.20	14.68
mesothelioma cell line:ONE58	10858-111G3	30.89	10.30
migratory langerhans cells, donor1	11901-125F2	66.41	16.89
migratory langerhans cells, donor2	11902-125F3	77.91	14.04
migratory langerhans cells, donor3	11903-125F4	89.02	19.20
mixed mullerian tumor cell line:HTMMT	10689-109F5	33.95	14.04
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	22.04	14.20
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	85.92	16.82
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	68.89	4.57
myelodysplastic syndrome cell line:SKM-1	10772-110F7	77.06	22.36
myeloma cell line:PCM6	10474-106I6	67.21	14.23
myxofibrosarcoma cell line:MFH-ino	10600-108E6	38.05	16.74
myxofibrosarcoma cell line:NMFH-1	10684-109E9	33.15	17.06
nasal epithelial cells, donor1, tech_rep1	12226-129F3	23.62	6.02
nasal epithelial cells, donor1, tech_rep2	12226-129F3	19.56	6.32
nasal epithelial cells, donor2	12227-129F4	43.61	11.04
neuroblastoma cell line:CHP-134	10508-107D4	135.51	99.85
neuroblastoma cell line:NB-1	10539-107G8	137.32	49.95
neuroblastoma cell line:NBsusSR	10607-108F4	38.59	59.68
neuroblastoma cell line:NH-12	10555-107I6	74.35	70.63
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	35.82	42.23
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	32.63	42.76
neuroectodermal tumor cell line:TASK1	10774-110F9	25.76	21.94
neuroepithelioma cell line:SK-N-MC	10728-110A8	45.78	34.33
neurofibroma cell line:Hs 53.T	10729-110A9	25.29	17.30
neutrophil PMN, donor1	12133-128D9	59.50	14.87
neutrophil PMN, donor2	12137-128E4	92.96	0.00
neutrophil PMN, donor3	12141-128E8	47.35	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	307.12	137.49
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	84.85	52.83
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	21.80	23.40
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	30.48	10.51
nucleus accumbens, adult, pool1	10037-101F1	80.33	63.93
occipital cortex - adult, donor10196	10172-103C1	94.78	51.51
occipital cortex, adult, donor10252	10163-103B1	122.91	74.07
occipital cortex, newborn, donor10223	10355-105E4	48.40	28.39
occipital lobe, adult, donor1	10076-102A4	59.04	57.47
occipital lobe, fetal, donor1	10073-102A1	37.76	50.20
occipital pole, adult, pool1	10036-101E9	52.51	38.63
olfactory region, adult	10195-103E6	68.40	46.43
optic nerve, donor1	10277-104E7	126.07	52.03
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	57.41	28.14
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	98.92	43.28
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	41.48	15.24
oral squamous cell carcinoma cell line:SAS	10544-107H4	42.28	14.32
osteoclastoma cell line:Hs 706.T	10704-109H2	25.28	18.81
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	134.54	21.49
osteosarcoma cell line:HS-Os-1	10558-107I9	43.90	38.81
ovary, adult, pool1	10020-101D2	58.53	47.96
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	43.81	28.96
pancreas, adult, donor1	10049-101G4	37.63	17.87
pancreatic carcinoma cell line:NOR-P1	10698-109G5	48.36	6.99
papillary adenocarcinoma cell line:8505C	10437-106E5	21.63	12.10
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	72.86	21.53
paracentral gyrus, adult, pool1	10035-101E8	66.72	54.64
parietal cortex, adult, donor10258	10373-105G4	68.26	45.51
parietal lobe - adult, donor10196	10171-103B9	76.18	49.85
parietal lobe, adult, donor10252	10157-103A4	96.91	60.43
parietal lobe, adult, pool1	10034-101E7	63.18	49.79
parietal lobe, fetal, donor1	10072-101I9	58.19	88.25
parietal lobe, newborn, donor10223	10356-105E5	34.40	28.41
parotid gland, adult	10199-103F1	32.68	13.57
penis, adult	10200-103F2	45.12	23.10
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	42.02	26.59
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	55.95	23.31
pineal gland - adult, donor10196	10179-103C8	125.78	56.12
pineal gland, adult, donor10252	10160-103A7	167.00	106.60
pineal gland, adult, donor10258	10377-105G8	89.67	39.51
pituitary gland - adult, donor10196	10180-103C9	129.51	99.16
pituitary gland, adult, donor10252	10162-103A9	179.81	124.04
pituitary gland, adult, donor10258	10378-105G9	82.57	50.22
placenta, adult, pool1	10021-101D3	83.31	33.43
plasma cell leukemia cell line:ARH-77	10840-111E3	88.33	38.67
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	32.68	21.17
pons, adult, pool1	10033-101E6	85.64	61.45
postcentral gyrus, adult, pool1	10032-101E5	51.52	38.71
promyelocytes/myelocytes PMC, donor1	12132-128D8	106.66	33.46
promyelocytes/myelocytes PMC, donor2	12136-128E3	11.02	5.51
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00
prostate cancer cell line:DU145	10490-107B4	106.19	38.02
prostate cancer cell line:PC-3	10439-106E7	68.43	44.47
prostate, adult, pool1	10022-101D4	64.03	37.55
putamen, adult, donor10196	10176-103C5	100.56	64.21
putamen, adult, donor10252	10152-102I8	76.47	39.21
putamen, adult, donor10258, tech_rep1	10372-105G3	43.71	25.13
putamen, adult, donor10258, tech_rep2	10372-105G3	65.24	31.89
putamen, newborn, donor10223	10365-105F5	44.23	91.46
rectal cancer cell line:TT1TKB	10469-106I1	64.59	16.58
rectum, fetal, donor1	10067-101I4	61.20	30.60
renal cell carcinoma cell line:OS-RC-2	10411-106B6	23.53	18.44
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	84.08	11.18
retina, adult, pool1	10030-101E3	53.68	44.13
retinoblastoma cell line:Y79	10475-106I7	114.05	67.03
rhabdomyosarcoma cell line:KYM-1	10787-110H4	64.18	30.98
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	116.14	79.58
sacrococcigeal teratoma cell line:HTST	10695-109G2	40.92	23.49
salivary acinar cells, donor1	11771-123I7	42.89	21.53
salivary acinar cells, donor2	11772-123I8	38.97	20.65
salivary acinar cells, donor3	11773-123I9	59.58	31.78
salivary gland, adult, pool1	10093-102C3	48.04	13.73
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	38.53	10.20
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	28.57	11.87
seminal vesicle, adult	10201-103F3	91.53	30.16
serous adenocarcinoma cell line:JHOS-2	10639-108I9	27.94	20.41
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	16.10	19.88
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	25.09	29.10
serous cystadenocarcinoma cell line:HTOA	10693-109F9	38.42	33.85
signet ring carcinoma cell line:Kato III	10436-106E4	59.91	24.65
signet ring carcinoma cell line:NUGC-4	10483-107A6	46.32	16.13
skeletal muscle - soleus muscle, donor1	10282-104F3	51.07	12.77
skeletal muscle, adult, pool1	10023-101D5	61.29	24.59
skeletal muscle, fetal, donor1	10066-101I3	19.10	16.08
skin, adult, donor1	10074-102A2	20.36	0.00
skin, fetal, donor1	10065-101I2	59.34	38.50
small cell cervical cancer cell line:HCSC-1	10800-110I8	55.03	62.04
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	59.57	54.85
small cell lung carcinoma cell line:DMS 144	10841-111E4	74.79	43.75
small cell lung carcinoma cell line:LK-2	10541-107H1	83.24	50.77
small cell lung carcinoma cell line:NCI-H82	10842-111E5	56.78	60.48
small cell lung carcinoma cell line:WA-hT	10562-108A4	100.02	49.69
small intestine, adult, pool1	10024-101D6	95.08	24.01
small intestine, fetal, donor1	10064-101I1	50.86	28.99
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	35.90	32.31
smooth muscle, adult, pool1	10048-101G3	53.24	30.24
somatostatinoma cell line:QGP-1	10781-110G7	58.43	32.43
spinal cord - adult, donor10196	10181-103D1	69.74	53.91
spinal cord, adult, donor10252	10159-103A6	103.30	66.63
spinal cord, adult, donor10258	10369-105F9	63.65	61.57
spinal cord, fetal, donor1	10056-101H2	63.42	66.47
spinal cord, newborn, donor10223	10359-105E8	71.18	70.26
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	28.23	14.49
spleen, adult, pool1	10025-101D7	93.61	31.72
spleen, fetal, pool1	10044-101F8	70.64	35.12
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	53.21	24.33
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	62.85	15.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	62.55	48.57
squamous cell carcinoma cell line:T3M-5	10616-108G4	46.91	11.73
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	93.09	53.24
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	27.53	16.52
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	58.38	13.96
stomach, fetal, donor1	10062-101H8	41.65	23.50
submaxillary gland, adult	10202-103F4	48.42	21.65
substantia nigra - adult, donor10196	10178-103C7	162.82	0.00
substantia nigra, adult, donor10252	10158-103A5	109.05	62.52
substantia nigra, adult, donor10258	10371-105G2	63.62	40.35
substantia nigra, newborn, donor10223	10358-105E7	40.27	43.81
synovial sarcoma cell line:HS-SY-II	10441-106E9	69.93	73.82
temporal lobe, adult, pool1	10031-101E4	48.57	38.99
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	39.89	51.28
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	54.94	61.54
tenocyte, donor1	11763-123H8	33.51	21.64
tenocyte, donor2	11765-123I1	30.14	11.45
tenocyte, donor3	11768-123I4	20.39	11.12
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	141.41	63.57
teratocarcinoma cell line:NCR-G1	10798-110I6	56.26	38.38
teratocarcinoma cell line:PA-1	10807-111A6	111.12	68.35
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	107.52	58.65
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	100.59	53.70
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	158.90	43.62
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	132.89	99.34
testis, adult, pool1	10026-101D8	116.28	76.56
testis, adult, pool2	10096-102C6	139.84	100.59
thalamus - adult, donor10196	10168-103B6	107.09	65.14
thalamus, adult, donor10252	10154-103A1	117.99	79.55
thalamus, adult, donor10258, tech_rep1	10370-105G1	30.79	18.48
thalamus, adult, donor10258, tech_rep2	10370-105G1	46.11	30.96
thalamus, newborn, donor10223	10366-105F6	30.49	46.03
throat, adult	10209-103G2	59.92	22.22
throat, fetal, donor1	10061-101H7	49.06	34.13
thymic carcinoma cell line:Ty-82	10803-111A2	57.23	44.12
thymus, adult, pool1	10027-101D9	151.21	62.03
thymus, fetal, pool1	10043-101F7	118.66	54.97
thyroid carcinoma cell line:KHM-5M	10776-110G2	26.33	12.50
thyroid carcinoma cell line:TCO-1	10783-110G9	22.91	17.46
thyroid, adult, pool1	10028-101E1	85.01	36.67
thyroid, fetal, donor1	10060-101H6	61.17	41.66
tongue epidermis (fungiform papillae), donor1	10288-104F9	58.51	21.56
tongue, adult	10203-103F5	41.40	20.47
tongue, fetal, donor1	10059-101H5	33.89	22.07
tonsil, adult, pool1	10047-101G2	76.93	26.85
trachea, adult, pool1	10029-101E2	68.30	33.37
trachea, fetal, donor1	10058-101H4	45.78	41.55
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	28.34	13.82
transitional-cell carcinoma cell line:5637	10418-106C4	61.50	29.18
transitional-cell carcinoma cell line:JMSU1	10492-107B6	108.11	25.07
tridermal teratoma cell line:HGRT	10694-109G1	34.25	30.44
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	35.21	17.78
umbilical cord, fetal, donor1	10057-101H3	27.12	29.21
uterus, adult, pool1	10100-102D1	77.64	52.21
uterus, fetal, donor1	10055-101H1	46.59	45.56
vagina, adult	10204-103F6	65.91	29.73
vein, adult	10191-103E2	58.96	20.17
xeroderma pigentosum b cell line:XPL 17	10563-108A5	50.74	13.62